| abstract |
The present invention relates generally to changes in gene expression in human tissues obtained from cancer patients. Specifically, the present invention relates to expression in cancer tissues of breast, colon, esophagus, kidney, liver, lung, lymph node, ovary, pancreas, prostate, rectum and / or stomach compared to expression in corresponding normal tissue. Related to different human genes. |